Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CASA trial in older postmenopausal women with endocrine-nonresponsive early breast cancer
ACTRN12606000077561Phase 3Completed
- Sponsor
- Breast Cancer Trials
- Start
- Apr 2006
- Modality
- Small Molecules, Liposomes → Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of pegylated liposomal doxorubicin in breast cancer, sponsored by Breast Cancer Trials. Primary endpoint: Breast cancer free interval. Started Apr 2006; status: completed.
02
Drugs
pegylated liposomal doxorubicin
03
Conditions
breast cancer
Beyond the preview
Go deeper on ACTRN12606000077561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12606000077561.